Dr Ronold R Tesch, MD | |
2311 Yorkshire Drive, Suite C, Brookings, SD 57006-2446 | |
(605) 692-7315 | |
(605) 692-2615 |
Full Name | Dr Ronold R Tesch |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 2311 Yorkshire Drive, Brookings, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184608622 | NPI | - | NPPES |
6300020 | Medicaid | SD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 2023 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ronold R Tesch, MD 2311 Yorkshire Drive, Suite C Yorkshire Eye Clinic, Brookings, SD 57006-2446 Ph: (605) 692-7315 | Dr Ronold R Tesch, MD 2311 Yorkshire Drive, Suite C, Brookings, SD 57006-2446 Ph: (605) 692-7315 |
News Archive
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
Knowles Electronics announced today that Judge Rogers of the International Trade Commission (ITC) issued his Initial Determination in which he found that Knowles was likely to succeed in showing that its patents cover Analog Devices, Inc. (ADI) MEMS microphone products.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist Quadrivalent (Influenza Vaccine Live, Intranasal) for prevention of influenza.
› Verified 9 days ago
Dr. Kenneth J Knudtson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2311 Yorkshire Drive, Ste C, Brookings, SD 57006 Phone: 605-692-7315 Fax: 605-692-2615 |